EA201792545A1 - Способы и наборы для лечения депрессии - Google Patents
Способы и наборы для лечения депрессииInfo
- Publication number
- EA201792545A1 EA201792545A1 EA201792545A EA201792545A EA201792545A1 EA 201792545 A1 EA201792545 A1 EA 201792545A1 EA 201792545 A EA201792545 A EA 201792545A EA 201792545 A EA201792545 A EA 201792545A EA 201792545 A1 EA201792545 A1 EA 201792545A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- depression
- kits
- methods
- treatment
- treating depression
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Organic Chemistry (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Emergency Medicine (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Steroid Compounds (AREA)
- Treatments Of Macromolecular Shaped Articles (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562164026P | 2015-05-20 | 2015-05-20 | |
| PCT/US2016/033404 WO2016187491A1 (en) | 2015-05-20 | 2016-05-20 | Methods and kits for treating depression |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EA201792545A1 true EA201792545A1 (ru) | 2018-05-31 |
Family
ID=57320901
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA201792545A EA201792545A1 (ru) | 2015-05-20 | 2016-05-20 | Способы и наборы для лечения депрессии |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US20160338977A1 (https=) |
| EP (1) | EP3297618A4 (https=) |
| JP (1) | JP2018515557A (https=) |
| KR (1) | KR20180008634A (https=) |
| CN (1) | CN107735081A (https=) |
| AU (3) | AU2016263598A1 (https=) |
| CA (1) | CA2986477A1 (https=) |
| CL (1) | CL2017002904A1 (https=) |
| CO (1) | CO2017011564A2 (https=) |
| DO (1) | DOP2017000268A (https=) |
| EA (1) | EA201792545A1 (https=) |
| EC (1) | ECSP17077930A (https=) |
| GT (1) | GT201700246A (https=) |
| HK (1) | HK1252937A1 (https=) |
| IL (1) | IL255463A (https=) |
| MA (1) | MA42135A (https=) |
| MX (1) | MX2017014797A (https=) |
| PE (1) | PE20180260A1 (https=) |
| PH (1) | PH12017502103A1 (https=) |
| WO (1) | WO2016187491A1 (https=) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20200404A1 (es) | 2013-03-15 | 2020-02-26 | Janssen Pharmaceutica Nv | Composicion farmaceutica de clorhidrato de s-ketamina |
| CN106714789A (zh) | 2014-08-13 | 2017-05-24 | 詹森药业有限公司 | 用于治疗抑郁症的方法 |
| CN107208133A (zh) | 2014-09-15 | 2017-09-26 | 詹森药业有限公司 | 用于治疗抑郁症的Val66Met (SNPrs6265)基因型特异性给药方案和方法 |
| US20160332962A1 (en) | 2015-05-13 | 2016-11-17 | Janssen Pharmaceutica Nv | (s)-csa salt of s-ketamine, (r)-csa salt of s-ketamine and processes for the preparation of s-ketamine |
| US11191734B2 (en) | 2015-06-27 | 2021-12-07 | Shenox Pharmaceuticals, Llc | Ketamine transdermal delivery system |
| US20200009081A1 (en) | 2017-09-13 | 2020-01-09 | Janssen Pharmaceutica N.V. | Delivery Of Esketamine For The Treatment Of Depression |
| MX2020006650A (es) | 2017-12-22 | 2020-11-06 | Janssen Pharmaceuticals Inc | Esketamina para el tratamiento de la depresión. |
| PL3505157T3 (pl) | 2017-12-29 | 2022-04-11 | Celon Pharma S.A. | Kompozycja ketaminy w postaci suchego proszku do podawania dopłucnego w leczeniu depresji opornej na leczenie |
| JP2021529732A (ja) * | 2018-06-27 | 2021-11-04 | クレキシオ バイオサイエンシーズ エルティーディー． | 大うつ病性障害の処置方法 |
| EP3628313B1 (en) * | 2018-09-28 | 2025-02-12 | Novohale Therapeutics, LLC | Ketamine composition for use in a method of treatment of depression by pulmonary administration |
| WO2020070547A1 (en) * | 2018-10-05 | 2020-04-09 | Clexio Biosciences Ltd. | Dosage regime of esketamine for treating major depressive disorder |
| KR20210074275A (ko) | 2018-10-05 | 2021-06-21 | 클렉시오 바이오사이언시스 리미티드 | 주요 우울 장애를 치료하기 위한 에스케타민의 복용 요법 |
| WO2020070706A1 (en) * | 2018-10-05 | 2020-04-09 | Clexio Biosciences Ltd. | Dosage regime of esketamine for treating major depressive disorder |
| US12364672B2 (en) | 2018-10-11 | 2025-07-22 | Clexio Biosciences Ltd. | Esketamine for use in treating major depressive disorder |
| MX2021010683A (es) * | 2019-03-05 | 2021-12-10 | Janssen Pharmaceuticals Inc | Esketamina para el tratamiento de la depresión. |
| US20220304950A1 (en) * | 2019-08-28 | 2022-09-29 | Janssen Pharmaceuticals, Inc. | Esketamine for the treatment of patients with major depressive disorder, including suicidality |
| TW202135787A (zh) | 2019-12-12 | 2021-10-01 | 比利時商健生藥品公司 | 艾氯胺酮調配物及製備與儲存的方法 |
| WO2021137147A1 (en) | 2019-12-30 | 2021-07-08 | Clexio Biosciences Ltd. | Dosage regime with esketamine for treating major depressive disorder |
| JP2023507926A (ja) | 2019-12-30 | 2023-02-28 | クレキシオ バイオサイエンシーズ エルティーディー． | 神経精神状態または神経学的状態を治療するためのエスケタミンを用いた投与計画 |
| WO2021242504A1 (en) * | 2020-05-28 | 2021-12-02 | Janssen Pharmaceuticals, Inc. | Methods for treating depression |
| GB202019952D0 (en) * | 2020-12-17 | 2021-02-03 | Neurocentrx Pharma Ltd | Novel compositions |
| WO2022235576A1 (en) * | 2021-05-03 | 2022-11-10 | Wang Michael Z | Methods and compositions for treating depression |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007111880A2 (en) * | 2006-03-22 | 2007-10-04 | Mount Sinai School Of Medicine | Intranasal administration of ketamine to treat depression |
| US20110038807A1 (en) * | 2009-08-14 | 2011-02-17 | Demitri Papolos | Compositions and methods for treating bipolar disorder |
| WO2013003669A2 (en) * | 2011-06-30 | 2013-01-03 | University Of South Florida | Compositions, methods of use, and methods of treatment |
| PE20141906A1 (es) * | 2012-03-12 | 2014-12-05 | Janssen Pharmaceutica Nv | Esketamina para el tratamiento de la depresion refractaria al tratamiento o resistente al tratamiento |
| EP2830604A4 (en) * | 2012-03-30 | 2015-08-19 | Gen Hospital Corp | COMPOSITIONS WITH SCOPOLAMINE AND KETAMINE FOR THE TREATMENT OF DEPRESSIONS |
| JP6462663B2 (ja) * | 2013-04-12 | 2019-01-30 | アイカーン スクール オブ メディシン アット マウント シナイ | 心的外傷後ストレス障害を処置するための方法 |
| CN107208133A (zh) * | 2014-09-15 | 2017-09-26 | 詹森药业有限公司 | 用于治疗抑郁症的Val66Met (SNPrs6265)基因型特异性给药方案和方法 |
-
2016
- 2016-05-19 US US15/159,257 patent/US20160338977A1/en not_active Abandoned
- 2016-05-20 CA CA2986477A patent/CA2986477A1/en not_active Abandoned
- 2016-05-20 CN CN201680029082.XA patent/CN107735081A/zh active Pending
- 2016-05-20 JP JP2017560314A patent/JP2018515557A/ja active Pending
- 2016-05-20 MX MX2017014797A patent/MX2017014797A/es unknown
- 2016-05-20 EP EP16797348.6A patent/EP3297618A4/en not_active Withdrawn
- 2016-05-20 EA EA201792545A patent/EA201792545A1/ru unknown
- 2016-05-20 PE PE2017002425A patent/PE20180260A1/es unknown
- 2016-05-20 MA MA042135A patent/MA42135A/fr unknown
- 2016-05-20 AU AU2016263598A patent/AU2016263598A1/en not_active Abandoned
- 2016-05-20 WO PCT/US2016/033404 patent/WO2016187491A1/en not_active Ceased
- 2016-05-20 KR KR1020177036002A patent/KR20180008634A/ko not_active Withdrawn
- 2016-05-20 HK HK18112292.0A patent/HK1252937A1/zh unknown
-
2017
- 2017-11-06 IL IL255463A patent/IL255463A/en unknown
- 2017-11-14 CO CONC2017/0011564A patent/CO2017011564A2/es unknown
- 2017-11-15 CL CL2017002904A patent/CL2017002904A1/es unknown
- 2017-11-16 GT GT201700246A patent/GT201700246A/es unknown
- 2017-11-17 DO DO2017000268A patent/DOP2017000268A/es unknown
- 2017-11-20 PH PH12017502103A patent/PH12017502103A1/en unknown
- 2017-11-23 EC ECIEPI201777930A patent/ECSP17077930A/es unknown
-
2021
- 2021-08-11 AU AU2021215155A patent/AU2021215155A1/en not_active Abandoned
-
2023
- 2023-09-25 AU AU2023237026A patent/AU2023237026A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20160338977A1 (en) | 2016-11-24 |
| AU2016263598A8 (en) | 2017-11-30 |
| AU2023237026A1 (en) | 2023-10-12 |
| EP3297618A1 (en) | 2018-03-28 |
| PE20180260A1 (es) | 2018-02-05 |
| JP2018515557A (ja) | 2018-06-14 |
| IL255463A (en) | 2018-01-31 |
| PH12017502103A1 (en) | 2018-05-07 |
| AU2016263598A1 (en) | 2017-11-23 |
| HK1252937A1 (zh) | 2019-06-06 |
| CL2017002904A1 (es) | 2018-04-20 |
| MX2017014797A (es) | 2018-02-15 |
| EP3297618A4 (en) | 2019-01-23 |
| AU2021215155A1 (en) | 2021-09-02 |
| MA42135A (fr) | 2018-03-28 |
| GT201700246A (es) | 2019-07-29 |
| CN107735081A (zh) | 2018-02-23 |
| WO2016187491A1 (en) | 2016-11-24 |
| CO2017011564A2 (es) | 2018-04-19 |
| DOP2017000268A (es) | 2018-04-15 |
| CA2986477A1 (en) | 2016-11-24 |
| KR20180008634A (ko) | 2018-01-24 |
| ECSP17077930A (es) | 2018-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201792545A1 (ru) | Способы и наборы для лечения депрессии | |
| CY1125144T1 (el) | Φαρμακευτικη συνθεση, μεθοδοι θεραπειας και χρηση αυτης | |
| SA519401522B1 (ar) | Lag-3 أجـسـام مـضـادة لـ وتـركـيـبـات | |
| ZA202005388B (en) | Methods of treating ulcerative colitis | |
| PH12019501018A1 (en) | Pharmaceutical composition, methods for treating and uses thereof | |
| MX2021012155A (es) | Composiciones y metodos para el tratamiento de la anemia. | |
| EA201691877A1 (ru) | Человеческие антитела к спайк-белку коронавируса ближневосточного респираторного синдрома | |
| EA201790142A1 (ru) | Лечение лейкоза ингибиторами гистондеацетилазы | |
| EA201691866A1 (ru) | Проникающие в опухоль лимфоциты для адоптивной клеточной терапии | |
| EA201791460A1 (ru) | N4-гидроксицитидин и связанные с ним производные и варианты противовирусного применения | |
| EA201790195A1 (ru) | Способы лечения рака с применением ингибиторов tigit и противораковых агентов | |
| EA201692511A1 (ru) | Комбинированное лечение ингибиторами глутаминазы | |
| EA201992251A1 (ru) | Противораковые вакцины и способы лечения с их применением | |
| EA201790787A1 (ru) | Снижение вязкости фармацевтических составов | |
| BR112017021312A2 (pt) | tratamento de câncer de pulmão com inibidores de glutaminase | |
| EA201591543A1 (ru) | Комбинированные терапии для лечения рака с применением микрорнк и ингибиторов egfr-tki | |
| EA201891664A1 (ru) | Составы/композиции, содержащие ингибитор btk | |
| EA201592203A1 (ru) | Способы лечения таупатии | |
| MX2022011972A (es) | Composiciones que comprenden anticuerpos contra il6r para el tratamiento de la uveitis y el edema macular, y metodos de uso de las mismas. | |
| EA201891527A1 (ru) | Композиции и способы обнаружения и лечения рака пищевода | |
| EA201892287A1 (ru) | Фармацевтические комбинации для лечения рака | |
| EA201792641A1 (ru) | Ингибитор оси igfbp3/tmem219 и диабет | |
| MX2018001369A (es) | Combinaciones de inhibidores de tirosina quinasa de bruton y sus usos. | |
| UY38352A (es) | Inhibidores de integrina alfavbeta6 | |
| BR112017014914A2 (pt) | terapia combinada para hipertensão pulmonar |